Tags

Type your tag names separated by a space and hit enter

Atorvastatin vs simvastatin or pravastatin for cholesterol lowering in primary hypercholesterolemia and mixed dyslipidemias

Atorvastatin vs simvastatin or pravastatin for cholesterol lowering in primary hypercholesterolemia and mixed dyslipidemias is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

"Atorvastatin Vs Simvastatin or Pravastatin for Cholesterol Lowering in Primary Hypercholesterolemia and Mixed Dyslipidemias." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454736/all/Atorvastatin_vs_simvastatin_or_pravastatin_for_cholesterol_lowering_in_primary_hypercholesterolemia_and_mixed_dyslipidemias.
Atorvastatin vs simvastatin or pravastatin for cholesterol lowering in primary hypercholesterolemia and mixed dyslipidemias. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/454736/all/Atorvastatin_vs_simvastatin_or_pravastatin_for_cholesterol_lowering_in_primary_hypercholesterolemia_and_mixed_dyslipidemias. Accessed August 21, 2019.
Atorvastatin vs simvastatin or pravastatin for cholesterol lowering in primary hypercholesterolemia and mixed dyslipidemias. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/454736/all/Atorvastatin_vs_simvastatin_or_pravastatin_for_cholesterol_lowering_in_primary_hypercholesterolemia_and_mixed_dyslipidemias
Atorvastatin Vs Simvastatin or Pravastatin for Cholesterol Lowering in Primary Hypercholesterolemia and Mixed Dyslipidemias [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 August 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454736/all/Atorvastatin_vs_simvastatin_or_pravastatin_for_cholesterol_lowering_in_primary_hypercholesterolemia_and_mixed_dyslipidemias.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Atorvastatin vs simvastatin or pravastatin for cholesterol lowering in primary hypercholesterolemia and mixed dyslipidemias ID - 454736 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454736/all/Atorvastatin_vs_simvastatin_or_pravastatin_for_cholesterol_lowering_in_primary_hypercholesterolemia_and_mixed_dyslipidemias PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -